NIH-funded research Fellowship grant

Investigating how PIKfyve affects tumor growth and pH balance in pancreatic cancer

Official title: PIKfyve regulates pH homeostasis and tumor growth in pancreatic cancer

Funded at Sanford Burnham Prebys Medical Discovery Institute · NIH-11067511 · Data updated 2026-11-12

This study is looking at a protein called PIKfyve to see how it affects the growth of pancreatic cancer cells, and it hopes to find new ways to help improve treatment for people battling this tough disease.

More Pancreatic Cancer research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionSanford Burnham Prebys Medical Discovery Institute
NIH-funded
Lab location1 site (La Jolla, United States)
Project startMay 16, 2025
Project endMay 15, 2028
Funding year2025
Award (this year)$40,810
NIH project number1F31CA298202-01
Project IDNIH-11067511 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma who are seeking innovative treatment options.

Less likely to help

Patients with other types of cancer or those who do not have pancreatic cancer may not benefit from this research.

What this research studies

This research focuses on pancreatic ductal adenocarcinoma (PDAC), a highly aggressive cancer with a low survival rate. It aims to explore the role of PIKfyve, a protein involved in cellular processes, in regulating the tumor environment and cancer cell growth. By inhibiting PIKfyve using a specific drug, the study will assess its effects on cancer cell survival and proliferation in laboratory settings. The goal is to identify new therapeutic strategies that could improve treatment outcomes for patients with this challenging disease.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options that significantly improve survival rates for patients with pancreatic cancer.

How similar studies have gone: Previous research has shown promising results in targeting PIKfyve in other cancers, suggesting potential for success in pancreatic cancer as well.

Where this research is happening

  • Sanford Burnham Prebys Medical Discovery Institute
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Grenier Davis, Shea — Sanford Burnham Prebys Medical Discovery Institute
  • Study coordinator: Grenier Davis, Shea

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.